Aug 31, 2026 08:02AM
Apr 22, 2026 05:14PM
Sep 24, 2025 12:48PM
Sep 22, 2025 07:16AM
Sep 16, 2025 07:19AM
Jul 22, 2025 07:28AM
Jul 21, 2025 07:52AM Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
Jul 11, 2025 07:02AM
Jun 17, 2025 06:45AM
May 27, 2025 08:50AM
May 13, 2025 07:52AM
May 12, 2025 07:04AM
Apr 3, 2025 07:33AM
Mar 26, 2025 06:49AM Cantor Fitzgerald Reiterates Overweight Rating on Kalvista Pharmaceuticals Inc (KALV)
Mar 13, 2025 06:58AM
Feb 26, 2025 09:37AM
Feb 19, 2025 06:55AM
Feb 14, 2025 07:06AM
Feb 13, 2025 09:28AM
Feb 13, 2025 06:32AM
Jan 29, 2025 09:12AM Cantor Fitzgerald provides update on Biotechnology stocks
Dec 31, 2024 06:37AM
Aug 1, 2024 06:35AM
Jul 11, 2024 06:36AM
Apr 16, 2024 06:31AM
Mar 1, 2024 02:37PM
Feb 15, 2024 02:56PM
Dec 7, 2023 05:18AM AbbVie (ABBV) to acquire Cerevel (CERE) for $8.7 billion; deal 'makes sense' says analyst
Sep 22, 2023 06:32AM
Apr 25, 2023 06:33AM
Feb 9, 2023 08:00AM
Dec 1, 2022 09:05AM
Sep 29, 2022 08:30AM
Sep 29, 2022 06:46AM
May 2, 2022 08:00AM Beacon Pointe Sprouts Two New Offices in Spring 2022
Apr 20, 2022 06:36AM
Apr 8, 2022 06:38AM
Mar 23, 2022 09:55AM
Mar 16, 2022 07:04AM
Mar 10, 2022 01:43PM
Mar 9, 2022 01:08PM
Mar 1, 2022 08:29AM Novavax (NVAX) Stock Falls 6% on Weak Sales Guidance, Analyst Remains Positive
Feb 18, 2022 06:49AM
Feb 18, 2022 06:34AM
Jan 31, 2022 07:22AM
Jan 10, 2022 06:36AM
Jan 4, 2022 07:58AM
Dec 20, 2021 11:39AM
Dec 17, 2021 06:46AM Cantor Fitzgerald Starts Cardiol Therapeutics (CRDL) at Overweight
Nov 8, 2021 06:21AM

420 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All